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Edited by Maurice MontalAbstract Saccharomyces cerevisiae has only one gene encoding
a putative voltage-gated Ca2+ channel pore-forming subunit,
CCH1, which is not possible to be cloned by conventional
molecular cloning techniques using Escherichia coli. Here, we
report the successful cloning of CCH1 in yeast by in vivo
homologous recombination without using E. coli. Overexpression
of the cloned CCH1 or MID1 alone, which encodes a putative
stretch-activated Ca2+ channel component, does not increase
Ca2+ uptake activity, but co-overexpression results in a 2- to 3-
fold increase. Overexpression of CCH1 does not substantially
complement the lethality and low Ca2+ uptake activity of a mid1
mutant and vice versa. These results indicate that co-overpro-
duction of Cch1 and Mid1 is suﬃcient to increase Ca2+ uptake
activity.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The Saccharomyces cerevisiae CCH1 gene product, Cch1,
has sequence similarity to the a1 pore-forming subunit of the
dihydropyridine-sensitive (L-type) family of mammalian
voltage-gated Ca2þ channels [1,2]. In contrast, the MID1 gene
product, Mid1, has no overall sequence similarity to known
mammalian ion channels except for potential transmembrane
segments [3], although it has stretch-activated Ca2þ-perme-
able channel activity when expressed in mammalian cells
[4,5]. Genetic analyses showed that yeast cells lacking CCH1
or MID1 and those lacking both genes have the same phe-
notype, including low Ca2þ uptake activity and loss of via-
bility after exposure to the mating pheromone a-factor [1,2].
It is hypothesized that the Cch1 and Mid1 proteins are nec-* Corresponding author. Fax: +81-42-329-7517.
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doi:10.1016/j.febslet.2004.09.021essary constituents of a common Ca2þ inﬂux system [1,2,6–9],
and this is supported by the observation that Mid1 co-
immunoprecipitates with Cch1 [6]. However, it cannot be
proven by gene disruption analysis that these two proteins
are suﬃcient for the formation of the Ca2þ inﬂux system. To
overcome this obstacle, molecular cloning of the encoding
genes and consequent in vivo or in vitro reconstitution ex-
periments are essential. Unfortunately, the molecular cloning
of CCH1 is not possible using conventional techniques with
Escherichia coli, because the CCH1 sequence is harmful to
this organism [2].
In S. cerevisiae, the ends of DNA molecules are extremely
recombigenic [10], allowing for targeted recombination be-
tween two DNA molecules which have homologous sequences
at their ends. Based upon this property, in vivo cloning tech-
niques have been developed that co-transform a linearized
vector with a gene of interest [11–13]. In the present study, we
employed this technique to clone the CCH1 gene in a cch1
mutant and found that the cloned gene complements the mu-
tation, thereby indicating that it is functional. A further study
showed that overexpression of CCH1 or MID1 from a multi-
copy plasmid does not increase Ca2þ uptake activity, but co-
overexpression induces a 2- to 3-fold increase in growing and
mating pheromone-treated cells, suggesting that overproduc-
tion of Cch1 and Mid1 is suﬃcient to increase Ca2þ uptake
activity. The co-overexpression system is useful for functional
analysis of animal, plant and fungal Ca2þ-permeable channel
candidates and their regulators.2. Materials and methods
2.1. Yeast strains and media
The yeast genetic manipulation and recombinant DNA techniques
were previously described [14,15]. E. coli strain DH5a was used
(Toyobo Co., Osaka). The isogenic wild-type yeast strains used were
H207 (MATa his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2) and H208
(MATa his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2) [3]. The following
mutant strains are derivatives of H207: H311 (MATa mid1-D5::HIS3)
[16], H313 (MATa cch1D::TRP1) and H315 (MATa cch1D::TRP1
mid1-D5::HIS3). To construct H312, H313 and H315, the CCH1-
knockout plasmid pKC289 (a gift from K.W. Cunningham) [6] was cut
with EcoRI and introduced into H208. Successful disruption of the
CCH1 gene was conﬁrmed by PCR and tetrad analysis. The resulting
strain, H314 (MATa cch1D::TRP1), was crossed with H311 (MATa
mid1-D5::HIS3), and the diploids formed were sporulated and dis-
sected. A Trp Hisþ segregant (MATa mid1-D5::HIS3) was designatedation of European Biochemical Societies.
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nated H313, and a Trpþ Hisþ segregant (MATa cch1D::TRP1
mid1D5::HIS3) was designated H315.
Rich medium YPD and synthetic media SD and SD.Ca100 were
prepared as previously described [3]. The SD.Ca100 medium contained
100 lM CaCl2, while SD medium contained 681 lM CaCl2.
2.2. Plasmids
Yeast shuttle vectors YCplac33 [CEN4 URA3], YCplac111 [CEN4
LEU2], YEplac195 [2 lm URA3] and YEplac181 [2 lm LEU2] were
gifts from Akio Sugino [17]. YCpMID1 [CEN4 URA3 MID1], YEp-
MID1 [2 lm URA3 MID1] and YEpMID1 [2 lm LEU2 MID1] were
constructed by inserting the MID1-containing BamHI–XhoI fragment
of YCpMID1-23 [3] between the BamHI and SalI sites of YCplac33,
YEplac195 and YEplac181, respectively. To construct YCp33Rec
[CEN4 URA3] and YEp195Rec [2 lm URA3], the vectors used for in
vivo homologous recombination, the Rec sequence, a 105 bp EcoRI-
BamHI fragment of pGADT7-Rec (BD Biosciences Clontech, Palo
Alto, CA) was inserted between the EcoRI and BamHI sites located in
the multi-cloning site (MCS) of YCplac33 and YEplac195, respectively.
The Rec sequence has a SmaI site 40 bp downstream of the EcoRI site.
2.3. Cloning of CCH1
The PCR primers used are listed in Table 1. To clone the CCH1 gene
by in vivo homologous recombination, it was ampliﬁed by PCR with
LA Taq DNA polymerase (Takara Bio Inc., Otsu, Shiga) using
primers No. 1 and No. 2 (Table 1), which possess a part of the CCH1
non-coding region and vector sequence, and chromosomal DNA of the
wild-type strain H207 as a template (see Fig. 1). The PCR products
were mixed with linearized YCp33Rec or YEp195Rec, which had been
cut with EcoRI and SmaI, and co-introduced into strain H313
(cch1D::TRP1). The resulting transformants were examined for the
presence of the CCH1 gene and ﬂanking primer sequences by PCR
analysis with Ex Taq DNA polymerase (Takara Bio Inc.), and se-
quence-positive transformants were further examined for viability 8 h
after the addition of a-factor. If the construction of CCH1-carrying
plasmids was successful, the transformants were viable like wild-type
strains because of the presence of functional CCH1. Viable strains
were selected and single colony isolation was repeated twice. The
conﬁrmed strains were designated H313/YCpCCH1Rec and H313/
YEpCCH1Rec.Table 1
PCR primers used in this study
No. Sequence Primer
1   CCH1-5’-500 5’-GGGTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTG 
CTGCAGTAGAATTGCATAAATTTCAGCTTGGGT-3’ 
2   CCH1-3’-142 5’-GTATCGATGCCCACCCTCTAGAGGCCGAGGCGGCCGACA
GCGCATTTTTTTCTTTTCTTTTTTCCC-3’
3    CCH1-5’-500F-Kpn 5’-GGGGTACCTAGAATTGCATAAATTTCAGCTTGGGT-3’ 
4   CCH1-5’R-Bam 5’-GGGGATCCAGTACTAACAATATATTCTATTTAGTAATG-3’
5    CCH1-3’F-Pst 5’-CCCTGCAGTAAATTATATAAGGGCATATTTAAGAGG-3’ 
6    CCH1-3’-142R-Sph 5’-GGGCATGCGCATTTTTTTCTTTTCTTTTTTCCC-3’ 
7    CCH1-5’F-Bam 5’-GGGATCCATGCAGGGGAGAAAAAGGACGCT-3’ 
8   CCH1-5’-72R-Xho 5’-CCCTCGAGTGCTGCATTGTCCCCAAATGGA-3’
9   CCH1-3’-67F-Xho 5’-CCCTCGAGGATGGAGCCCCCGGAAGAAC-3’
10   CCH1-3’R-PstSal 5’-CCCTGCAGGTCGACTCTATCAATTAGATCATTTGCGCTATC-3’
11   GFP-5’F-Sal 5’-GGGTCGACAGTAAAGGAGAAGAACTT-3’
12   GFP-3’R-Pst 5’-CCCTGCAGGTCGATCGAGTTATTTGTATAGTTCATCCAT-3’ 
Underlines represent the sequences corresponding to each end of the
linearized vector.
Double underlines represent 27-nucleotide sequences corresponding to
500–474 nucleotides upstream of the initiation codon of CCH1 and to
116–142 nucleotides downstream of the stop codon, respectively.
Boxes indicate restriction sites used to construct the plasmids.
Bold triplets indicate the stop and initiation codons.To construct wild-type strains carrying YEpCCH1Rec, H313/YE-
pCCH1Rec cells were mated with H208 (MATa CCH1þ trp1-289 ura3-
52) cells, and the resulting diploids were sporulated and dissected.
Trp Uraþ segregants were assessed for the presence of the CCH1 gene
and ﬂanking primer sequences by PCR analysis, and sequence-positive
segregants were designated H207/YEpCCH1Rec. Likewise, to con-
struct mid1 mutants carrying YEpCCH1Rec, H313/YEpCCH1Rec
cells were mated with H312 (MATa mid1-D5::HIS3 trp1-289 ura3-52)
cells, and Trp Uraþ Hisþ segregants were selected as described above
and designated H311/YEpCCH1Rec.
2.4. Construction of Cch1-GFP and Cch1-HAx4
To construct plasmids carrying genes encoding Cch1 tagged with
green ﬂuorescence protein (GFP) or with four times-repeated hemag-
glutinin (HAx4) at the C-terminus of Cch1 by in vivo homologous
recombination, we ﬁrst constructed plasmids (named GFP-plus plas-
mids or HAx4-plus plasmids) that carried the 50-non-coding (500 bp),
50-coding (72 bp) and 30-coding (67 bp) regions of CCH1, the tag (GFP
or HAx4), and the 30-non-coding region (142 bp) of CCH1, in which
each tag was located just before the stop codon of CCH1. These re-
gions were ampliﬁed by PCR with LA Taq DNA polymerase and the
following sets of primers: for the ampliﬁcation of the 50-non-coding
region, the primers No. 3 and No. 4 were used; for the 30-non-coding
region, No. 5 and No. 6; for the 50-coding region, No. 7 and No. 8; and
for the 30-coding region, No. 9 and No. 10. As a template, DNA
prepared from H313/YEpCCH1Rec was used. The resulting PCR
products were cut with the appropriate restriction enzymes and in-
serted stepwise into YCplac111 and YEplac181. The GFP sequence
ampliﬁed with primers No. 11 and No. 12 and the template plasmid
pS65T-C1 (BD Biosciences Clontech) followed by digestion with SalI
and PstI were inserted into the resulting plasmids cut with SalI and
PstI to give the GFP-plus plasmids. Likewise, the HAx4 sequence
obtained from pUSR-cof-HA1 [18] was inserted into the resulting
plasmids to give the HAx4-plus plasmids. The GFP-plus and HAx4-
plus plasmids were linearized with XhoI and introduced into cch1D
cells with the CCH1 sequence ampliﬁed by PCR using primers No. 7
and No. 10 and chromosomal DNA of the wild-type strain as a tem-
plate. The resulting transformants were then examined by PCR and
cell viability was assessed to determine whether it contained plasmids
carrying the fusion genes encoding functional Cch1-GFP or Cch1-
HAx4. Successful plasmids were designated YCpCCH1-GFP,
YCpCCH1-HAx4, YEpCCH1-GFP and YEpCCH1-HAx4.
2.5. Fluorescence microscopy and immunoblotting
Fluorescence microscopy on cells expressing Cch1-GFP or Mid1-
GFP was performed as described previously [16]. Immunoblot analysis
was carried out according to the method described previously [3] ex-
cept that SDS–PAGE samples were heated for 3 min at 70 C. A
mouse monoclonal antibody against the HA-tag (12CA5, Babco,
Berkeley, CA) and aﬃnity-puriﬁed rabbit antibodies against the C-
terminal peptide of Mid1 [19] were used to detect Cch1-HAx4 and
Mid1, respectively.
2.6. Determination of Ca2þ accumulation
Exponentially growing cells or those treated with 6 lM a-factor in
SD.Ca100 medium were incubated with 185 kBq of 45CaCl2 per ml (1.8
kBq/nmol). At appropriate intervals, samples were taken, ﬁltered
through Millipore ﬁlters (type HA; 0.45 lm) that had been presoaked
in 5 mM CaCl2 and washed ﬁve times with the same solution. The
radioactivity retained on the ﬁlters was counted with a scintillation
mixture, Ready Protein (Beckman Japan, Tokyo), in a liquid scintil-
lation counter.
2.7. Determination of shmoos and viability
The methods used were previously described [3].
2.8. Statistical analysis
Results are shown as meansS.D. from at least three independent
experiments. Statistical signiﬁcance was determined for Fig. 2A using a
one-way ANOVA followed by the Sheﬀe’s method of a multiple
comparison test, with a maximum P value of <0.05 required for sig-
niﬁcance. We did not perform statistical analysis for other ﬁgures, such
as Fig. 2B, Figs. 3 and 4, because the generations of each sample diﬀer
from strain to strain in terms of the horizontal axis of the ﬁgures.
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Fig. 1. Scheme of the cloning of the CCH1 gene by in vivo homologous
recombination in yeast. The CCH1 gene was ampliﬁed by PCR using
primers containing sequences homologous to a linearized plasmid at
both ends. The PCR product was mixed with the linearized plasmid
and co-transformed into yeast cells, in which homologous recombi-
nation occurred to produce a plasmid containing the CCH1 gene.
Abbreviations used: I, initiation codon; T, termination codon; ORF,
open reading frame; E, EcoRI site; S, SmaI site; B, BamHI site.
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Fig. 2. Ca2þ accumulation of cells overexpressing CCH1, MID1 or
both in the exponentially growing phase. Exponentially growing cells
of WT, CCH1ox,MID1ox, and CCH1oxMID1ox strains in SD.Ca100
medium received 185 kBq/ml (1.8 kBq/nmol) 45CaCl2 at time 0 and
were then examined for Ca2þ accumulation at the indicated times.
Ca2þ accumulation is shown as a function of time (A) and generation
(B) as the abscissa axis. Data are means S.D. from at least three
independent experiments. In (A), statistical analysis showed that Ca2þ
accumulation in CCH1ox MID1ox cells was signiﬁcantly greater than
that in WT, CCH1ox, and MID1ox cells (P < 0:05).
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3.1. Cloning of CCH1 by in vivo homologous recombination
Since several research groups including ours could not clone
the CCH1 gene by conventional cloning methods using E. coli
as a host [2], we employed another method using in vivo ho-
mologous recombination in S. cerevisiae. The CCH1-open
reading frame (ORF) with 50-500 bp and 30-142 bp ﬂanking
regions fused with sequences homologous to the ends of line-
arized vector YCp33Rec [URA3] (low-copy) and YEp195Rec
[URA3] (multi-copy) was ampliﬁed by PCR using primers No.
1 and No. 2 listed in Table 1. The 50-primer (No. 1) contained
the distal 27 nucleotides of the 50-ﬂanking region and a part of
the vector sequence, and the 30-primer (No. 2) contained the
distal 27 nucleotides of the 30-ﬂanking region and a part of the
Rec sequence in the vectors. The PCR products and the line-
arized YCp33Rec or YEp195Rec were co-introduced into the
cch1 null mutant H313 (Fig. 1), and the resulting Uraþ
transformants were examined for the presence of the CCH1
sequence by PCR analysis. Sequence-positive transformants
were then examined to determine whether the cloned CCH1
gene was able to complement the a-factor-induced death
phenotype of the cch1 mutant. To carry this out, six trans-
formants containing YEp195Rec with CCH1 were randomlyselected and incubated for 8 h with a-factor, after which cell
viability was determined. Their viability was 53–82%, whereas
the viability of cch1 mutant containing the empty vector YE-
p195Rec (H313/YEp195Rec) was 6.6 3.9% (n ¼ 3). This in-
dicates that the CCH1 gene cloned in this way was functional.
Similar results were obtained for transformants containing
YCp33Rec with CCH1 (data not shown). We named the
complementing plasmid YCpCCH1Rec or YEpCCH1Rec and
H313 strains bearing this plasmid H313/YCpCCH1Rec or
H313/YEpCCH1Rec. The viability of H313/YEpCCH1Rec
(53–82%) was slightly lower than that of wild-type strain H207
bearing the empty vector (88%; n ¼ 3). However, we believe
that it was not due to the partial activity of the cloned CCH1
gene carrying a putative loss-of-function mutation, because the
viability of the mid1 mutant bearing YEpMID1 or YCpMID1,
which possess the MID1 gene with no mutation, was also
slightly lower than that of the wild-type strains. However, we
cannot exclude this possibility, since DNA sequencing was not
applicable for CCH1 gene cloned in yeast cells. Therefore, we
examined the YEpCCH1Rec plasmid that possessed the
highest complementing activity hereafter.
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MID1 or both after exposure to a-factor. (A) The viability of WT,
MID1ox, CCH1ox and CCH1ox MID1ox cells was determined after
the addition of 6 lM a-factor by the methylene blue liquid method [3].
Data are means S.D. from at least three independent experiments.
(B) Ca2þ accumulation of each strain. Exponentially growing cells of
each strain in SD.Ca100 medium received 6 lM a-factor and 185 kBq/
ml (1.8 kBq/nmol) 45CaCl2 at time 0. Data are meansS.D. from at
least three independent experiments.
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replicate in E. coli. The plasmids were isolated from H313/
YEpCCH1Rec and H313/YCpCCH1Rec strains and intro-
duced into E. coli by conventional transformation techniques.
However, no transformant was obtained.
To transfer YEpCCH1Rec to the wild-type strains, H313/
YEpCCH1Rec was crossed with a MATa wild-type strain,
H208, and the resulting diploids were sporulated and dissected.
From the segregants, MATa wild-type strains carrying YE-
pCCH1Rec, designated H207/YEpCCH1Rec, were selected
and used in further experiments. Hereafter, we call cells of the
H207/YEpCCH1Rec strain CCH1ox cells. Likewise, we call
H207/YEpMID1 cells MID1ox cells, H207 cells bearing both
YEpCCH1Rec and YEpMID1 CCH1ox MID1ox cells, and
H207 cells bearing the corresponding empty vectors WT cells
unless otherwise mentioned.3.2. CCH1-overexpression results in cell cycle retardation
CCH1ox cells grew more slowly in liquid and solid media
than WT cells. Therefore, we determined the mean doubling
time (TD) of cells grown in SD.Ca100 medium at 30 C. The TD
of CCH1ox cells was 4.2 0.2 h, whereas that ofMID1ox and
WT cells was 3.0 0.2 h. The TD of CCH1ox MID1ox cellswas 5.0 0.3 h. Therefore, overexpression of CCH1, but not
MID1, retards cell cycle progression and co-overexpression
of CCH1 and MID1 has an additional eﬀect on cell cycle
progression.
3.3. Co-overexpression of CCH1 and MID1 increases Ca2þ
uptake activity in growing cells
We examined the eﬀect of overexpression of CCH1 on Ca2þ
uptake activity. Cells of various strains were grown in
SD.Ca100 medium to the exponentially growing phase and
incubated further with 45CaCl2, after which Ca
2þ uptake ac-
tivity was measured. Since TD varies from strain to strain, the
data obtained were plotted against generation time as well as
incubation time (Fig. 2A and B). In all the strains examined,
only CCH1ox MID1ox cells showed elevated activity for the
initial Ca2þ uptake rate and longer term Ca2þ accumulation.
The Ca2þ uptake activity of CCH1ox cells was unchanged,
although cell cycle progression was retarded in this strain.
These results suggest that a Ca2þ channel in growing cells re-
quires the Cch1 and Mid1 proteins for their functionality. In
addition, cell cycle retardation caused by overexpression of
CCH1 is not due to increased Ca2þ inﬂux.
3.4. Co-overexpression of CCH1 and MID1 increases Ca2þ
uptake activity in a-factor-treated cells
Previous studies with mutants lacking CCH1,MID1 or both
showed that Cch1 and Mid1 co-operate in common Ca2þ in-
ﬂux systems including an a-factor-induced Ca2þ inﬂux system
[1,2,7]. Therefore, we examined if overexpression of CCH1 and
MID1 aﬀects cell viability and Ca2þ uptake activity after cells
were exposed to a-factor. Fig. 3A shows that the viability of
cells exposed to a-factor was the same among CCH1ox,
MID1ox, CCH1ox MID1ox, and WT cells, except that
CCH1ox MID1ox cells maintained a slightly higher viability
after three generations had passed. Fig. 3B shows that among
the four strains examined, only CCH1ox MID1ox cells pos-
sessed enhanced activity in initial Ca2þ uptake rate and longer
term Ca2þ accumulation. In contrast, CCH1ox cells did not
exhibit increased activity. MID1ox cells possess no elevated
activity [3]. It should be noted that overexpression of CCH1,
MID1 or both did not aﬀect dose–response curves to a-factor
and kinetics for diﬀerentiation into cells having a mating
projection (called shmoos) in response to a-factor, respectively
(data not shown). Therefore, the increase in the Ca2þ uptake
activity of CCH1oxMID1ox cells is not due to changes in their
sensitivity and responsiveness to a-factor.
3.5. Overexpression of CCH1 does not complement the mid1D
mutation
Molecular cloning of CCH1 on a multicopy plasmid in yeast
allowed us to test whether CCH1 can complement phenotypes
of the mid1D mutant when overexpressed. Exponentially
growing cells of H311/YEpCCH1Rec (mid1DCCH1ox) were
incubated with a-factor, and cell viability and Ca2þ uptake
activity were determined at appropriate intervals. Fig. 4A
shows that mid1DCCH1ox cells did not have a signiﬁcantly
higher viability than mid1D cells. In addition, Ca2þ uptake
activity was the same between mid1DCCH1ox and mid1D cells
(Fig. 4B). These results indicate that overexpression of CCH1
does not complement the mid1D mutation.
Fig. 4C shows that there was no signiﬁcant diﬀerence in
viability and Ca2þ uptake activity between cch1DMID1ox cells
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Fig. 4. Viability and Ca2þ accumulation of mid1D cells overexpressing
CCH1 and cch1D cells overexpressing MID1. (A and B) Viability and
Ca2þ accumulation of WT, mid1D and mid1D CCH1ox cells. Each
strain was the mid1D mutant H311 harboring YCpMID1 (low-copy),
empty vector YEplac195Rec or YEpCCH1Rec (multi-copy), respec-
tively. The generation time of each strain is as follows, wild-type, 2.4
0.1 h; mid1D, 4.4 0.1 h; mid1D CCH1ox, 4.3 0.3 h. (C and D) Vi-
ability and Ca2þ accumulation of WT, cch1D and cch1DMID1ox cells.
Each strain was the cch1D mutant H313 harboring YCpCCH1Rec
(low-copy), empty vector YEplac195 or YEpMID1 (multi-copy), re-
spectively. The generation time of each strain is as follows, wild-type,
2.8 0.1 h; cch1D, 4.8 0.5 h; cch1D MID1ox, 4.9 0.5 h. Experi-
mental conditions were the same as those in Fig. 3. All data are
meansS.D. from at least three independent experiments.
Fig. 5. Semi-quantitative estimation of the amount of overexpressed
Cch1 and Mid1. (A) H313 (cch1D) cells harboring YEplac181 (vector),
YCpCCH1-HAx4 (Cch1) or YEpCCH1-HAx4 (Cch1ox); (B) H311
(mid1D) cells harboring YEplac195 (vector), wild-type H207 cells
harboring YEplac195 (Mid1), or H311 cells harboring YEpMID1
(Mid1ox). Each cell type was cultured to the exponentially growing
phase and total cell extracts were prepared by homogenization with
glass-beads. The extracts for Cch1ox or Mid1ox cells were serially
diluted with the extracts of the corresponding vector-harboring cells.
Samples (20 lg protein each) were subjected to 4–20% SDS–PAGE
followed by immunoblotting with antibodies against the HA-tag or
C-terminal peptide of Mid1.
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expression does not complement the cch1D mutation.
3.6. Semi-quantitative analysis of overexpressed Cch1 and Mid1
proteins
The copy number of multicopy plasmids is usually 10–40 per
host cell [20]. Ca2þ uptake activity elevated by the co-overex-
pression of CCH1 and MID1 was only 2- to 3-fold, however
(Figs. 2 and 3). To investigate the cause of this discrepancy, we
performed an immunoblot analysis. The CCH1-HAx4 gene
encoding the Cch1 protein tagged with four hemagglutinin
(HA) antigens was cloned into a low copy and multicopy
plasmid in the cch1D mutant strain H313. The fusion gene
complemented the lethality of the cch1D mutant upon expo-
sure to a-factor (data not shown), indicating that the Cch1-
HAx4 protein was functional. Protein samples were prepared,
sequentially diluted, and subjected to immunoblotting. Fig. 5A
shows that under conditions where non-diluted Cch1-HAx4
from the low copy plasmid was barely detectable, a 32-fold-
diluted sample from the multicopy plasmid was still detectable.
This indicates that overexpression of CCH1 resulted in more
than a 32-fold increase in protein content. As for Mid1,overexpression of MID1 also resulted in an at least 32-fold
increase compared to the endogenous content (Fig. 5B).
It is possible that excess Cch1 produced from the multicopy
plasmid was mostly mislocalized. To investigate this possibil-
ity, the Cch1-GFP protein was produced from low copy and
multicopy plasmids and subjected to ﬂuorescence microscopy.
Cch1-GFP produced from the low copy plasmid was barely
observed (Fig. 6A), while that from the multicopy plasmid was
easily seen in the plasma membrane (Fig. 6B). Similar ﬂuo-
rescent images were obtained with Mid1-GFP (Fig. 6E and F).
It is noted that both Cch1-GFP and Mid1-GFP were also lo-
calized in an intracellular compartment. As for Mid1 and
Mid1-GFP, this compartment is shown to be the endoplasmic
reticulum (ER), and localization to the ER is not due to
overexpression from multicopy plasmids [16,19].
These data suggest that the 2- to 3-fold-increase in Ca2þ
uptake activity is not attributable to a small increase in Cch1
or Mid1 content or the mislocalization of Cch1 or Mid1. Why
is the increase in Ca2þ accumulation only 2–3-fold in CCH1ox
MID1ox cells irrespective of these facts? We suppose that it is
due to the presence of a cellular factor responsible for the
assembly or functional regulation of Cch1 and Mid1, and that
this factor is limiting in CCH1ox MID1ox cells. Further
studies are needed to identify such a factor. In the mating
process, an a-factor-inducible, cycloheximide-sensitive factor
has been suggested as a candidate [21].
It should be noted that measurements of Ca2þ accumula-
tion, the method we employed, do not necessarily point to an
increase in Ca2þ channel activity in CCH1ox MID1ox cells
and may detect changes in Ca2þ transport through other
means. However, considering that Cch1 is structurally ho-
mologous to mammalian voltage-gated Ca2þ channels [1,2]
and Mid1 has stretch-activated Ca2þ-permeable channel
Fig. 6. Subcellular localization of Mid1 and Cch1 in exponentially
growing cells. Exponentially growing cells of the cch1D mutant H313
harboring YCpCCH1-GFP (A, C) or YEpCCH1-GFP (B, D) and the
mid1D mutant H311 harboring YCpMID1-GFP (E, G) or YEpMID1-
GFP (F, H) in SD.Ca100 medium were observed by confocal
ﬂuorescence microscopy (A, B, E and F) or diﬀerential interference
contrast microscopy (C, D, G and H). Similar results were obtained for
two additional experiments.
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Ca2þ accumulation rate reﬂects an increase in Ca2þ channel
activity. Electrophysiological analysis is needed to clarify this
matter.
If Cch1 acts as a voltage-gated Ca2þ channel, how is it ac-
tivated in exponentially growing cells and those exposed to a-
factor? We have no data to answer this question at present, but
speculate that expansion of the plasma membrane accompa-
nied with budding and mating projection formation might
activate Mid1. The activated Mid1 might depolarize the
plasma membrane to activate Cch1.
In summary, while previous studies with the cch1, mid1 and
cch1 mid1 mutants have shown that Cch1 and Mid1 are nec-
essary components for Ca2þ inﬂux [1,2,7], our overexpression
experiments with the cloned CCH1 and MID1 genes clearly
indicate that they are suﬃcient components. The CCH1oxMID1ox strain may serve as a new tool to explore factors or
subunits that upregulate or downregulate the Cch1/Mid1
channel.
Finally, we would like to highlight the usefulness of the
present study. Many eukaryotic putative channels have been
cloned but not functionally proven to be channels (for exam-
ple, see [22]). The expression of such channels with and with-
out Mid1 in the yeast strains described here may solve this
problem.
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